| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.022 | 0.8 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.056 | 0.8 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.8 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |